| scholarly article | Q13442814 |
| P50 | author | Paul Kellam | Q24005990 |
| Sam J Wilson | Q61126694 | ||
| P2093 | author name string | Lucy Dalton-Griffin | |
| P2860 | cites work | Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension | Q24307473 |
| Regulation of hypoxia-inducible factor 1α is mediated by an O 2 -dependent degradation domain via the ubiquitin-proteasome pathway | Q24672316 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension | Q28244565 | ||
| Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1 | Q28282227 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1alpha -deficient chimeric mice | Q28584939 | ||
| XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks | Q28591575 | ||
| Hypoxia--a key regulatory factor in tumour growth | Q29547318 | ||
| The mammalian unfolded protein response | Q29547400 | ||
| Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes | Q29617594 | ||
| Kaposi sarcoma: a continuing conundrum. | Q30370801 | ||
| EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors | Q33261811 | ||
| Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line | Q33807199 | ||
| Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. | Q33863055 | ||
| Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma | Q33974675 | ||
| Restriction of lentivirus in monkeys | Q34154725 | ||
| Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy | Q34683604 | ||
| KSHV/HHV8-associated lymphomas. | Q34711929 | ||
| Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia | Q35019982 | ||
| Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors | Q35139228 | ||
| The unfolded protein response--a stress signaling pathway of the endoplasmic reticulum | Q35885345 | ||
| X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. | Q35914523 | ||
| The unfolded protein response: a novel component of the hypoxic stress response in tumors. | Q36326570 | ||
| Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1 | Q36366273 | ||
| "Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways | Q36540080 | ||
| Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma | Q37535731 | ||
| X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency | Q38297437 | ||
| Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays | Q38305362 | ||
| V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression | Q38341587 | ||
| Quantitative, fluorogenic probe PCR assay for detection of human herpesvirus 8 DNA in clinical specimens | Q39466435 | ||
| Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells | Q39596534 | ||
| Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
| Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. | Q40002946 | ||
| Up-regulation of Murid herpesvirus 4 ORF50 by hypoxia: possible implication for virus reactivation from latency. | Q40020501 | ||
| ER stress is involved in B cell antigen receptor ligation-induced apoptosis | Q40058707 | ||
| Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter | Q40075775 | ||
| Differential regulation of hypoxia-induced CXCR4 triggering during B-cell development and lymphomagenesis | Q40079539 | ||
| A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia | Q40106826 | ||
| B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus | Q40110061 | ||
| EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells | Q40219046 | ||
| XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. | Q40519913 | ||
| Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression | Q40537413 | ||
| Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus | Q40807418 | ||
| Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions | Q42049779 | ||
| Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates | Q45117910 | ||
| Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle | Q45413006 | ||
| Rapid B cell receptor-induced unfolded protein response in nonsecretory B cells correlates with pro- versus antiapoptotic cell fate | Q52038310 | ||
| p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. | Q52173333 | ||
| Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1 | Q63565692 | ||
| Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes | Q64377708 | ||
| Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein | Q77760836 | ||
| Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions | Q94028943 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | 7202-7209 | |
| P577 | publication date | 2009-04-29 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions | |
| P478 | volume | 83 |
| Q41927566 | 1, 25(OH)2 D3 Induces Reactivation and Death of Kaposi's Sarcoma-Associated Herpesvirus of Primary Effusion Lymphoma cells |
| Q91757226 | A role of hypoxia-inducible factor 1 alpha in Murine Gammaherpesvirus 68 (MHV68) lytic replication and reactivation from latency |
| Q38752511 | ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle. |
| Q38315444 | Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells. |
| Q40064939 | Deregulation of KSHV latency conformation by ER-stress and caspase-dependent RAD21-cleavage. |
| Q39152964 | Effects of the NEDD8-activating enzyme inhibitor MLN4924 on lytic reactivation of Kaposi's sarcoma-associated herpesvirus |
| Q36684858 | Epigenetic diversity of Kaposi’s sarcoma–associated herpesvirus |
| Q33583668 | Fine tuning of the UPR by the ubiquitin ligases Siah1/2. |
| Q36167973 | Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway. |
| Q92255602 | Herpesviruses and the Unfolded Protein Response |
| Q34795543 | Immune Evasion by Kaposi‘s Sarcoma-Associated Herpesvirus |
| Q36433852 | Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1. |
| Q91605042 | KSHV activates unfolded protein response sensors but suppresses downstream transcriptional responses to support lytic replication |
| Q30433391 | KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation |
| Q28080937 | KSHV reactivation and novel implications of protein isomerization on lytic switch control |
| Q35010647 | Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation |
| Q35801076 | Modulation of Immune System by Kaposi’s Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies |
| Q90319823 | Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis |
| Q38970026 | Murine gammaherpesvirus 68 reactivation from B cells requires IRF4 but not XBP-1. |
| Q52641575 | Nucleolar stress enhances lytic reactivation of the Kaposi's sarcoma-associated herpesvirus |
| Q86625310 | ORF50-dependent and ORF50-independent activation of the ORF45 gene of Kaposi's sarcoma-associated herpesvirus |
| Q35927487 | Oncogenic Herpesvirus Utilizes Stress-Induced Cell Cycle Checkpoints for Efficient Lytic Replication |
| Q42166459 | Oxidative Stress Induces Reactivation of Kaposi's Sarcoma-Associated Herpesvirus and Death of Primary Effusion Lymphoma Cells |
| Q38121335 | Oxygen tension level and human viral infections. |
| Q39284842 | Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update |
| Q38021339 | Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. |
| Q99591124 | Regulation of KSHV Latency and Lytic Reactivation |
| Q47228609 | Regulation of gammaherpesvirus lytic replication by endoplasmic reticulum stress-induced transcription factors ATF4 and CHOP. |
| Q39581099 | Role of the cellular transcription factor YY1 in the latent-lytic switch of Kaposi's sarcoma-associated herpesvirus |
| Q41932132 | The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target. |
| Q97069756 | The RNA quality control pathway nonsense-mediated mRNA decay targets cellular and viral RNAs to restrict KSHV |
| Q39639121 | X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma |
Search more.